Managed care assessment fee.
SB 485 creates a new managed care assessment fee on managed care organizations in Indiana, tied to years in which state-directed payments are made to hospitals under the Medicaid program. The fee is designed to generate the state’s share of Medicaid costs and is set at an aggregate amount equal to 28.5% of the hospital assessment fees collected under existing law, excluding certain incremental fees. The bill requires the Office of Medicaid Policy and Planning to seek federal CMS approval, allows the state to negotiate implementation terms, and provides that the fee must stop if CMS determines it is no longer a permissible health care-related tax eligible for federal matching funds.
The bill also changes how existing hospital assessment fee revenues are used in years when the new managed care fee is imposed, and it extends the current hospital assessment fee law from June 30, 2025, to June 30, 2027. It establishes a managed care assessment fund, sets out payment schedules, reconciliation procedures, audit authority, penalties for late payment, and possible sanctions including contract termination or suspension/revocation of operating authority for nonpayment. The bill authorizes the Office to adopt implementing rules, including retroactive rules to May 1, 2025, and declares an emergency.
The likely policy impact is on Indiana’s Medicaid financing structure and on managed care organizations that contract with the state. The bill shifts part of the financing burden for Medicaid state-directed payments from hospital assessment mechanisms to a new assessment on managed care organizations, while preserving federal compliance requirements. It also affects the Department of Insurance, the Family and Social Services Administration/Office of Medicaid Policy and Planning, and any managed care organization licensed or authorized in Indiana that meets the federal definition used in the bill.
The general sentiment reflected in the bill text is pragmatic and fiscally driven, with the measure framed as a financing tool to support Medicaid services rather than a broad policy change. Because there are no committee transcripts or recorded votes provided, there is no direct evidence of support or opposition in the available context. The structure of the bill suggests an emphasis on administrative implementation and federal approval, indicating that compliance and revenue stability are central concerns.
Notable points of potential contention include the imposition of a new fee on managed care organizations, the possibility of tiered or methodology-based assessments, and the bill’s reliance on CMS approval and waiver authority. Managed care organizations may object to the added financial burden, while hospitals and state budget officials may view the measure as a way to preserve Medicaid funding. The bill also creates enforcement mechanisms, including penalties and regulatory sanctions, which could be controversial among affected insurers and health plans.
SB 485 amends Indiana Code chapters governing hospital assessment fees and insurance to authorize a new managed care assessment fee, create a managed care assessment fund, and extend the existing hospital assessment fee law to June 30, 2027. It changes the use of hospital assessment fee revenues in fiscal years when the new fee is imposed, and it directs the Office of Medicaid Policy and Planning and the Department of Insurance to administer, reconcile, audit, and enforce the assessment. The bill affects managed care organizations operating in Indiana, especially those with Medicaid-related contracts, and is contingent on federal CMS approval and continued federal permissibility under Medicaid financing rules.
The available text suggests a generally supportive, budget-oriented approach focused on preserving Medicaid funding and aligning state financing with federal requirements. There is no committee transcript or vote record provided, so no direct public sentiment can be measured from debate or roll calls. The bill’s detailed administrative framework and emergency clause indicate urgency and a desire for implementation rather than ideological conflict, but the absence of recorded discussion leaves the level of support or opposition uncertain.
The main points of contention are likely to be the new fee imposed on managed care organizations, the method used to calculate the assessment, and the enforcement consequences for nonpayment. Managed care organizations may resist the added cost and the possibility of penalties, contract sanctions, or license action, while state officials may argue the fee is necessary to fund the state share of Medicaid services. Another possible point of dispute is the bill’s dependence on CMS approval and waiver authority, since the fee must comply with federal health care-related tax rules and could be discontinued if CMS rejects it.